Elin Inderhaug

About

Elin Inderhaug is a molecular geneticist whose work has significantly advanced the diagnosis of Marfan syndrome and related type-1 fibrillinopathies. Her primary research focuses on the detection of mutations in the *FBN1* gene, a notoriously challenging task given its enormous coding region of 8,600 base pairs spread across 65 exons. Inderhaug’s major contribution came with her landmark 2006 study, which established a rapid and efficient strategy for *FBN1* mutation detection by combining automated sample preparation with direct sequencing as the primary diagnostic approach. This work, cited over 20 times, streamlined what had previously been a labor-intensive process, enabling more reliable and faster clinical diagnoses for patients suspected of having Marfan syndrome. By tackling the complexity of the *FBN1* gene—which harbors more than 600 known mutations—Inderhaug helped bridge the gap between genetic research and practical clinical testing. Her methodological innovation remains a foundational reference for laboratories working on fibrillinopathies, underscoring her lasting impact on the field of molecular diagnostics and her dedication to improving patient outcomes through precise genetic analysis.

Research Focus

Key Achievements

Top Papers

1. 1
   Rapid and Efficient <i>FBN1</i> Mutation Detection Using Automated Sample Preparation and Direct Sequencing As the Primary Strategy

   20 citations · 2006

Key Collaborators

Contact & Links